GlaxoSmithKline to acquire Aiolos for up to $1.4 billion
我放心你带套猛
发表于 2024-1-9 16:39:32
290
0
0
Caixin News Agency, January 9th - GlaxoSmithKline announced on January 9th that it will acquire Aiolos Bio for a prepayment of $1 billion and a milestone payment of up to $400 million. Through the acquisition, GlaxoSmithKline has acquired Aiolos AIO-001.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Eating all the AI dividends, has Nvidia reached its end? Many hedge funds have started profit taking models
- The potential total transaction amount can reach up to $8.4 billion! Baili Tianheng and Baishi Meishi Squibb have reached a cooperation agreement
- Top 20 US stock trading volume: Apple will abandon its 10-year electric vehicle development plan and shift towards generative artificial intelligence
- AstraZeneca acquires pharmaceutical company Amolyt Pharm for up to $1.05 billion
- How many bulls are there in the US stock market? Bank of America predicts: another 34% increase within two years, at least by 2030!
